The Growth Hormone Research Society
Overview of GRS
The Growth Hormone Research Society (GRS) was founded in 1992 to provide a forum for the study and exchange of ideas on all aspects of growth hormone physiology, and diseases involving abnormalities of the GH axis. With over 400 members from more than 30 countries, the society represents a unique international body composed of clinicians, scientists, educators, and students. These individuals are committed to the advancement and dissemination of research and education on a milieu of medical and biological topics related to GH. Among these are GH deficiency, GH excess, and the use of GH and related products in the treatment of these diseases. The society holds biannual meetings in conjunction with its sister society, the IGF research society. The official publication of GRS is Pituitary (The Official Journal of the Pituitary Society and Growth Hormone Research Society).
Mission of GRS
The mission of the GRS is to promote scientific research and clinical advancement in the fields of growth hormone (GH) and insulin-like growth factors (IGFs).
This GRS consensus academic society conducts this mission as an independent, non-profit society that facilitates and evaluates advances in the physiology, pathology, diagnostics, therapeutics, and surveillance of GH/IGF-related disorders.
The GRS fosters collaborations between basic scientists, clinicians (paediatric and adult) and clinical investigators from both the public and private sectors to promote research.
The GRS conveys knowledge through the Society’s journal, scientific meetings and workshops.
Who should join
The GRS engages basic scientists, clinicians (paediatric and adult) and clinical investigators from both the public and the private sectors, to promote collaborative research and convey knowledge through our society’s journal, scientific meetings and workshops. Additionally, postdoctoral fellows, medical students, and graduate students are encouraged to join.